Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Synthesis of biologically active biotinylated muramyl dipeptides.

Grimes CL, Podolsky DK, O'Shea EK.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6061-3. doi: 10.1016/j.bmcl.2010.08.056. Epub 2010 Aug 17.

2.

Synthesis of biotinylated muramyl tripeptides with NOD2-stimulating activity.

Gisch N, Buske B, Heine H, Lindner B, Zähringer U.

Bioorg Med Chem Lett. 2011 Jun 1;21(11):3362-6. doi: 10.1016/j.bmcl.2011.04.005. Epub 2011 Apr 9.

PMID:
21530249
3.

Lipophilic Muramyl Dipeptide-Antigen Conjugates as Immunostimulating Agents.

Willems MM, Zom GG, Meeuwenoord N, Khan S, Ossendorp F, Overkleeft HS, van der Marel GA, Filippov DV, Codée JD.

ChemMedChem. 2016 Jan 19;11(2):190-8. doi: 10.1002/cmdc.201500196. Epub 2015 Jun 9.

PMID:
26059481
4.

Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells.

Chen D, Texada DE, Duggan C, Liang C, Reden TB, Kooragayala LM, Langford MP.

J Biol Chem. 2005 Jun 10;280(23):22425-36. Epub 2005 Apr 6.

5.

The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.

Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK.

J Am Chem Soc. 2012 Aug 22;134(33):13535-7. doi: 10.1021/ja303883c. Epub 2012 Aug 13.

6.

[A protein interaction network and cell signaling pathways activated by muramyl peptides].

Meshcheriakova EA, Andronova TM, Ivanov VT.

Bioorg Khim. 2010 Sep-Oct;36(5):581-95. Review. Russian.

PMID:
21063445
7.

Synthesis and biological evaluation of biotinyl hydrazone derivatives of muramyl peptides.

Blanot D, Lee J, Girardin SE.

Chem Biol Drug Des. 2012 Jan;79(1):2-8. doi: 10.1111/j.1747-0285.2011.01204.x. Epub 2011 Nov 4.

PMID:
21816004
8.

Synthesis of Diverse N-Substituted Muramyl Dipeptide Derivatives and Their Use in a Study of Human NOD2 Stimulation Activity.

Chen KT, Huang DY, Chiu CH, Lin WW, Liang PH, Cheng WC.

Chemistry. 2015 Aug 17;21(34):11984-8. doi: 10.1002/chem.201501557. Epub 2015 Jul 16.

PMID:
26226896
9.

Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.

Coulombe F, Fiola S, Akira S, Cormier Y, Gosselin J.

PLoS One. 2012;7(5):e36734. doi: 10.1371/journal.pone.0036734. Epub 2012 May 9.

10.

Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.

Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.

J Immunol. 2005 Aug 1;175(3):1956-64.

11.

RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs.

Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Núñez G.

J Immunol. 2007 Feb 15;178(4):2380-6.

12.

MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.

Cantó E, Moga E, Ricart E, Garcia-Bosch O, Garcia-Planella E, Juarez C, Vidal S.

Inflamm Bowel Dis. 2009 Nov;15(11):1686-96. doi: 10.1002/ibd.21013.

PMID:
19572373
13.

NOD2: a potential target for regulating liver injury.

Body-Malapel M, Dharancy S, Berrebi D, Louvet A, Hugot JP, Philpott DJ, Giovannini M, Chareyre F, Pages G, Gantier E, Girardin SE, Garcia I, Hudault S, Conti F, Sansonetti PJ, Chamaillard M, Desreumaux P, Dubuquoy L, Mathurin P.

Lab Invest. 2008 Mar;88(3):318-27. doi: 10.1038/labinvest.3700716. Epub 2008 Jan 28.

14.

Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation.

Marina-García N, Franchi L, Kim YG, Hu Y, Smith DE, Boons GJ, Núñez G.

J Immunol. 2009 Apr 1;182(7):4321-7. doi: 10.4049/jimmunol.0802197.

15.

MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.

Pan Q, Mathison J, Fearns C, Kravchenko VV, Da Silva Correia J, Hoffman HM, Kobayashi KS, Bertin J, Grant EP, Coyle AJ, Sutterwala FS, Ogura Y, Flavell RA, Ulevitch RJ.

J Leukoc Biol. 2007 Jul;82(1):177-83. Epub 2007 Apr 2.

PMID:
17403772
16.

The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells.

Ribes S, Adam N, Schütze S, Regen T, Redlich S, Janova H, Borisch A, Hanisch UK, Nau R.

J Neuroimmunol. 2012 Nov 15;252(1-2):16-23. doi: 10.1016/j.jneuroim.2012.07.012. Epub 2012 Aug 11.

PMID:
22889567
17.

Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants.

Turánek J, Ledvina M, Kasná A, Vacek A, Hríbalova V, Krejcí J, Miller AD.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-90-1.

PMID:
16823942
18.

A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.

Fujimura T, Yamasaki K, Hidaka T, Ito Y, Aiba S.

J Dermatol Sci. 2011 May;62(2):107-15. doi: 10.1016/j.jdermsci.2011.02.002. Epub 2011 Feb 22.

PMID:
21411292
19.

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA.

J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6.

20.

The distinct response of gammadelta T cells to the Nod2 agonist muramyl dipeptide.

Kerns HM, Jutila MA, Hedges JF.

Cell Immunol. 2009;257(1-2):38-43. doi: 10.1016/j.cellimm.2009.02.004.

Items per page

Supplemental Content

Write to the Help Desk